Centro Nacional de Biotecnologia, Madrid
Recent findings from Spain, the United States and Canada illuminate research in vaccines
Published in Law and Health Weekly, June 24th, 2006
Study 1: The immune response of vaccinia virus vectors can be enhanced by interferon gamma (IFN-gamma) or interleukin 12 (IL-12).
According to recent research published in the journal Virus Research, "Recombinants based on vaccinia virus vectors, especially on the highly attenuated modified vaccinia virus Ankara (MVA) strain, are now being tested in clinical trials for safety and immunogenicity, using prime/boost heterologous regimes of vaccination. Due to the limited replication capacity of MVA, it is necessary to develop procedures that can enhance the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Biotechnology Industry Organization
BIO names Tom DiLenge as general counsel - Chimerix, Inc.
Chimerix acquires lead compound library of antiviral agents from University of Michigan - City of Hope National Medical Center, Duarte
RNAi is developed as treatment for HIV-1 infection - Federal University of Minas Gerais
Researchers from Brazil, Italy and Portugal provide details of new studies and findings in the area of obesity - Free University of Amsterdam
Free University of Amsterdam researchers describe recent findings - Healthcare Costs
sanofi-aventis to provide access to prescription drugs for low-income Medicare patients - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
